Published in Brain on September 01, 2002
Stimulation of the subthalamic nucleus and impulsivity: release your horses. Ann Neurol (2009) 1.62
Midline frontal cortex low-frequency activity drives subthalamic nucleus oscillations during conflict. J Neurosci (2014) 1.59
Unilateral vs. bilateral STN DBS effects on working memory and motor function in Parkinson disease. Exp Neurol (2007) 1.53
Cognitive outcome 5 years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (2006) 1.44
Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease? J Neurol Neurosurg Psychiatry (2005) 1.31
Mapping Go-No-Go performance within the subthalamic nucleus region. Brain (2010) 1.26
Effects of deep brain stimulation of the subthalamic nucleus on inhibitory and executive control over prepotent responses in Parkinson's disease. Front Syst Neurosci (2013) 1.22
Neuropsychiatric effects of subthalamic neurostimulation in Parkinson disease. Nat Rev Neurol (2010) 1.17
Neural correlates of STN DBS-induced cognitive variability in Parkinson disease. Neuropsychologia (2008) 1.03
Deficits in inhibitory control and conflict resolution on cognitive and motor tasks in Parkinson's disease. Exp Brain Res (2011) 1.00
Conflict-related activity in the caudal anterior cingulate cortex in the absence of awareness. Biol Psychol (2008) 0.95
Subthalamic nucleus stimulation affects limbic and associative circuits: a PET study. Eur J Nucl Med Mol Imaging (2010) 0.94
Cognitive rehabilitation in Parkinson's disease: evidence from neuroimaging. Front Neurol (2011) 0.94
Subthalamic nucleus stimulation affects orbitofrontal cortex in facial emotion recognition: a PET study. Brain (2008) 0.93
Mechanisms of unilateral STN-DBS in patients with Parkinson's disease : a PET study. J Neurol (2008) 0.91
A fronto-striato-subthalamic-pallidal network for goal-directed and habitual inhibition. Nat Rev Neurosci (2015) 0.91
Influence of bilateral Stn-stimulation on psychiatric symptoms and psychosocial functioning in patients with Parkinson's disease. J Neural Transm (Vienna) (2005) 0.89
The subthalamic nucleus, oscillations, and conflict. Mov Disord (2015) 0.87
Underlying neurobiology and clinical correlates of mania status after subthalamic nucleus deep brain stimulation in Parkinson's disease: a review of the literature. J Neuropsychiatry Clin Neurosci (2012) 0.87
Subthalamic nucleus stimulation affects theory of mind network: a PET study in Parkinson's disease. PLoS One (2010) 0.84
Modulation of human time processing by subthalamic deep brain stimulation. PLoS One (2011) 0.84
SPECT and PET analysis of subthalamic stimulation in Parkinson's disease: analysis using a manual segmentation. J Neurol (2009) 0.84
Deep brain stimulation of the subthalamic nucleus improves reward-based decision-learning in Parkinson's disease. Front Hum Neurosci (2011) 0.83
Does subthalamic nucleus stimulation affect the frontal limbic areas? A single-photon emission computed tomography study using a manual anatomical segmentation method. Surg Radiol Anat (2005) 0.83
Modulations of the executive control network by stimulus onset asynchrony in a Stroop task. BMC Neurosci (2013) 0.81
Human Subthalamic Nucleus Theta and Beta Oscillations Entrain Neuronal Firing During Sensorimotor Conflict. Cereb Cortex (2015) 0.81
Motor and Nonmotor Circuitry Activation Induced by Subthalamic Nucleus Deep Brain Stimulation in Patients With Parkinson Disease: Intraoperative Functional Magnetic Resonance Imaging for Deep Brain Stimulation. Mayo Clin Proc (2015) 0.80
Deep brain stimulation of the subthalamic nucleus, but not dopaminergic medication, improves proactive inhibitory control of movement initiation in Parkinson's disease. Neurotherapeutics (2013) 0.79
Deep brain stimulation of the subthalamic nucleus modulates reward processing and action selection in Parkinson patients. J Neurol (2015) 0.78
Betting on DBS: Effects of subthalamic nucleus deep brain stimulation on risk taking and decision making in patients with Parkinson's disease. Neuropsychology (2014) 0.78
Load-Dependent Interference of Deep Brain Stimulation of the Subthalamic Nucleus with Switching from Automatic to Controlled Processing During Random Number Generation in Parkinson's Disease. J Parkinsons Dis (2015) 0.78
Do patient's get angrier following STN, GPi, and thalamic deep brain stimulation. Neuroimage (2010) 0.78
Spontaneous sleep modulates the firing pattern of parkinsonian subthalamic nucleus. Exp Brain Res (2005) 0.78
Decisional impulsivity and the associative-limbic subthalamic nucleus in obsessive-compulsive disorder: stimulation and connectivity. Brain (2016) 0.76
Impaired performance on the Wisconsin Card Sorting Test under left- when compared to right-sided deep brain stimulation of the subthalamic nucleus in patients with Parkinson's disease. J Neurol (2009) 0.76
Motor and non motor effects during intraoperative subthalamic stimulation for Parkinson's disease. J Neurol (2005) 0.76
Subthalamic nucleus deep brain stimulation impacts language in early Parkinson's disease. PLoS One (2012) 0.75
Effects of STN DBS on memory guided force control in Parkinson's disease (June 2007). IEEE Trans Neural Syst Rehabil Eng (2007) 0.75
Network effects of deep brain stimulation. J Neurophysiol (2015) 0.75
Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson's disease. JCI Insight (2017) 0.75
Retrospective estimation and correction of physiological fluctuation in functional MRI. Magn Reson Med (1995) 3.62
Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain (1992) 2.64
Evidence for lateral premotor and parietal overactivity in Parkinson's disease during sequential and bimanual movements. A PET study. Brain (1997) 2.15
Botulinum toxin A for axillary hyperhidrosis (excessive sweating). N Engl J Med (2001) 1.96
Functional anatomy of the mental representation of upper extremity movements in healthy subjects. J Neurophysiol (1995) 1.92
Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa. Brain (2001) 1.83
Intraoperative MR imaging increases the extent of tumor resection in patients with high-grade gliomas. AJNR Am J Neuroradiol (1999) 1.80
Striatal glucose consumption in chorea-free subjects at risk of Huntington's disease. J Neurol (1993) 1.71
What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport. German Dystonia Study Group. J Neurol Neurosurg Psychiatry (1998) 1.69
Cognitive deficits before treatment among patients with brain tumors. Neurosurgery (2000) 1.66
Social phobia in spasmodic torticollis. J Neurol Neurosurg Psychiatry (2001) 1.62
Low-frequency repetitive transcranial magnetic stimulation of the motor cortex in writer's cramp. Neurology (1999) 1.61
Critical illness polyneuropathy: clinical findings and outcomes of a frequent cause of neuromuscular weaning failure. Crit Care Med (1996) 1.52
Lasting cortical activation after repetitive TMS of the motor cortex: a glucose metabolic study. Neurology (2000) 1.46
Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease. Neurosci Lett (1992) 1.44
Transmodal sensorimotor networks during action observation in professional pianists. J Cogn Neurosci (2005) 1.42
[From neuromuscular blocker to analgesic. What is the value of botulinum toxin in pain therapy?]. MMW Fortschr Med (2002) 1.40
Pallidal stimulation: an alternative to pallidotomy? J Neurosurg (1997) 1.39
Smoking alters the relationship between maternal zinc intake and biochemical indices of fetal zinc status. Am J Clin Nutr (1992) 1.39
Epilepsy and criminal law. Med Sci Law (1992) 1.38
Mapping the network for planning: a correlational PET activation study with the Tower of London task. Brain (1999) 1.37
A functional magnetic resonance imaging study of the role of left posterior superior temporal gyrus in speech production: implications for the explanation of conduction aphasia. Neurosci Lett (2000) 1.34
Executive and mnemonic functions in early Huntington's disease. Brain (1996) 1.30
Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology (1999) 1.27
The role of the striatum and hippocampus in planning: a PET activation study in Parkinson's disease. Brain (2001) 1.26
Brain or vein--oxygenation or flow? On signal physiology in functional MRI of human brain activation. NMR Biomed (1994) 1.26
A positron emission tomographic study of subthalamic nucleus stimulation in Parkinson disease: enhanced movement-related activity of motor-association cortex and decreased motor cortex resting activity. Arch Neurol (1999) 1.23
Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction. J Neurol Neurosurg Psychiatry (1994) 1.21
Intraoperative magnetic resonance imaging to update interactive navigation in neurosurgery: method and preliminary experience. Comput Aided Surg (1997) 1.21
Cognitive performance in multiple system atrophy. Brain (1992) 1.21
Role of the human rostral supplementary motor area and the basal ganglia in motor sequence control: investigations with H2 15O PET. J Neurophysiol (1998) 1.19
Intrauterine exposure to low levels of lead: the status of the neonate. Arch Environ Health (1987) 1.15
Mechanisms for the formation of glycoxidation products in end-stage renal disease. Kidney Int (2000) 1.11
Specific hypothalamic activation during a spontaneous cluster headache attack. Neurology (2004) 1.10
Imaging the pre- and postsynaptic side of striatal dopaminergic synapses in idiopathic cervical dystonia: a SPECT study using [123I] epidepride and [123I] beta-CIT. Mov Disord (1998) 1.07
Neural correlates associated with impaired disgust processing in pre-symptomatic Huntington's disease. Brain (2004) 1.07
Parkinson's disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography. J Neurol Neurosurg Psychiatry (1997) 1.05
Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol. J Psychopharmacol (2008) 1.04
The effect of acetazolamide on regional cerebral blood oxygenation at rest and under stimulation as assessed by MRI. J Cereb Blood Flow Metab (1994) 1.04
Cognitive dysfunction and subjective complaints of cancer patients. a cross-sectional study in a cancer rehabilitation centre. Eur J Cancer (2004) 1.04
Fetal lead exposure: antenatal factors. Environ Res (1985) 1.04
Central motor processing in Huntington's disease. A PET study. Brain (1997) 1.03
Methylphenidate-induced improvements of various measures of attention in adults with attention deficit hyperactivity disorder. J Neural Transm (Vienna) (2006) 1.03
Clinical evaluation and follow-up results for intraoperative magnetic resonance imaging in neurosurgery. Neurosurgery (2000) 1.03
Diagnostic benefits of presurgical fMRI in patients with brain tumours in the primary sensorimotor cortex. Eur Radiol (2011) 1.02
The benefit of neuronavigation for neurosurgery analyzed by its impact on glioblastoma surgery. Neurol Res (2000) 1.01
Active deep brain stimulation during MRI: a feasibility study. Magn Reson Med (2004) 1.01
"Silent event-related" fMRI reveals reduced sensorimotor activation in laryngeal dystonia. Neurology (2005) 1.00
Comparison of mercury levels in maternal blood, fetal cord blood, and placental tissues. Am J Obstet Gynecol (1981) 1.00
Cortical correlates of gesture processing: clues to the cerebral mechanisms underlying apraxia during the imitation of meaningless gestures. Neuroimage (2001) 0.99
Effects of surgery on cognitive functioning of elderly patients with intracranial meningioma. Br J Neurosurg (2001) 0.99
Depression in Parkinson's disease: brainstem midline alteration on transcranial sonography and magnetic resonance imaging. J Neurol (1999) 0.98
Time-resolved fMRI of activation patterns in M1 and SMA during complex voluntary movement. J Neurophysiol (2001) 0.97
Novel ATP1A3 mutation in a sporadic RDP patient with minimal benefit from deep brain stimulation. Neurology (2008) 0.97
Distinct striatal regions for planning and executing novel and automated movement sequences. Neuroimage (2008) 0.97
Deep brain stimulation for the treatment of Parkinson's disease: subthalamic nucleus versus globus pallidus internus. J Neurol Neurosurg Psychiatry (2001) 0.96
Proximal myotonic myopathy with MRI white matter abnormalities of the brain. Neurology (1997) 0.96
[Deep brain stimulation in the posterior hypothalamus for chronic cluster headache. Case report and review of the literature]. Schmerz (2006) 0.96
Differential modulation of subcortical target and cortex during deep brain stimulation. Neuroimage (2003) 0.95
[German guidelines for brain tumour imaging by PET and SPECT using labelled amino acids]. Nuklearmedizin (2011) 0.92
Dose standardization of botulinum toxin. Mov Disord (1998) 0.92
Hypothalamic activation in trigeminal autonomic cephalgia: functional imaging of an atypical case. Cephalalgia (2004) 0.92
Image-guided neurosurgery with intraoperative MRI: update of frameless stereotaxy and radicality control. Stereotact Funct Neurosurg (1997) 0.91
X-linked dilated cardiomyopathy. Novel mutation of the dystrophin gene. Ann N Y Acad Sci (1995) 0.91
Altered metabolism in frontal brain circuits in cluster headache. Cephalalgia (2007) 0.91
Verbal and figural fluency in patients with mass lesions of the left or right frontal lobes. J Clin Exp Neuropsychol (1999) 0.91
Cortical control of movement in Huntington's disease. A PET activation study. Brain (1997) 0.90
Pallidal stimulation for generalized dystonia. Report of three cases. J Neurosurg (2000) 0.90
Brain muscarinic receptors in Alzheimer's and Parkinson's diseases. Lancet (1989) 0.90
Neurological multisystem manifestation in multiple symmetric lipomatosis: a clinical and electrophysiological study. Muscle Nerve (1995) 0.89
[Deep brain stimulation for Parkinson's disease. Consensus recommendations of the German Deep Brain Stimulation Association]. Nervenarzt (2009) 0.89
Kinematic analysis of dopaminergic effects on skilled handwriting movements in Parkinson's disease. J Neural Transm (Vienna) (2005) 0.88
Severe multiple sclerosis relapse under fingolimod therapy: incident or coincidence? Neurology (2012) 0.88
Radiotherapy of aggressive fibromatosis. Eur J Cancer (1992) 0.88
Gait analysis in patients with advanced Parkinson disease: different or additive effects on gait induced by levodopa and chronic STN stimulation. J Neural Transm (Vienna) (2005) 0.88
Facial expression recognition and subthalamic nucleus stimulation. J Neurol Neurosurg Psychiatry (2004) 0.87
Glutamatergic-dopaminergic balance in the brain. Its importance in motor disorders and schizophrenia. Arzneimittelforschung (1992) 0.87
Pallidotomy in Parkinson's disease increases supplementary motor area and prefrontal activation during performance of volitional movements an H2(15)O PET study. Brain (1997) 0.87
Neuropsychological assessment of attention in adults with different subtypes of attention-deficit/hyperactivity disorder. J Neural Transm (Vienna) (2008) 0.87
Restoration of thalamocortical activity after posteroventral pallidotomy in Parkinson's disease. Lancet (1994) 0.87